TY - JOUR
T1 - Oncological resection and perioperative outcomes of robotic, laparoscopic and open pancreatoduodenectomy for ampullary adenocarcinoma
T2 - a propensity score matched international multicenter cohort study
AU - Uijterwijk, Bas A.
AU - Moekotte, Alma
AU - Boggi, Ugo
AU - Mazzola, Michele
AU - Groot Koerkamp, Bas
AU - Dalle Valle, Raffaele
AU - Koek, Sharnice
AU - Bolm, Louisa
AU - Mazzotta, Alessandro
AU - Luyer, Misha
AU - Goh, Brian K.P.
AU - Suarez Muñoz, Miguel A.
AU - Björnsson, Bergthor
AU - Kazemier, Geert
AU - Ielpo, Benedetto
AU - Pessaux, Patrick
AU - Kleeff, Jorg
AU - Ghorbani, Poya
AU - Mavroeidis, Vasileios K.
AU - Fusai, Giuseppe K.
AU - Salvia, Roberto
AU - Zerbi, Alessandro
AU - Roberts, Keith J.
AU - Alseidi, Adnan
AU - Al-Sarireh, Bilal
AU - Serradilla-Martín, Mario
AU - Vladimirov, Miljana
AU - Korkolis, Dimitris
AU - Soonawalla, Zahir
AU - Gruppo, Mario
AU - Bouwense, Stefan A.W.
AU - Vollmer, Charles M.
AU - Behrman, Stephen W.
AU - Christein, John D.
AU - Besselink, Marc G.
AU - Abu Hilal, Mohammed
AU - Webber, Laurence
AU - Wellner, Ulrich
AU - Ramaekers, Mark
AU - Sparrelid, Ernesto
AU - Malleo, Giuseppe
AU - Ramirez-Del Val, Alejandro
AU - Lancelotti, Francesco
AU - Nappo, Gennaro
AU - Halle-Smith, James
AU - Kent, Tara S.
AU - de Vos-Geelen, Judith
AU - de Wilde, Anouk
AU - Lemmers, Daniël H.
AU - Bhogal, Ricky
AU - International Study Group on non-pancreatic periampullary Cancer (ISGACA)
N1 - Publisher Copyright:
© 2024
PY - 2025/3
Y1 - 2025/3
N2 - Background: Ampullary adenocarcinoma (AAC) typically presents at an early stage due to biliary obstruction and therefore might be specifically suitable for minimally invasive pancreatoduodenectomy (MIPD). However, studies assessing MIPD specifically for AAC, including the robotic and laparoscopic approach, are limited. The aim of this study is to compare short- and long-term oncological resection and perioperative outcomes of robotic (RPD), laparoscopic (LPD) and open pancreatoduodenectomy (OPD) performed specifically for AAC. Methods: In this multicenter international cohort study, encompassing 35 centers from 11 countries, MIPD versus OPD and subgroup analyses of LPD versus RPD were undertaken. The primary outcomes regarded the oncological resection (R1 resection rate, lymph node yield) and 5-years overall survival. Secondary outcomes were perioperative outcomes (including intra-operative variables, surgical complications and hospital stay). Results: In total, patients with AAC who underwent OPD (1721) or MIPD (141) were included. After propensity-score matching, 134 patients per cohort were included. The MIPD group consisted of 53 RPDs and 71 LPDs (50 per group after PSM). There was no difference in overall survival between MIPD and OPD (61.6 % vs 56.2 %, P = 0.215). In the MIPD group, operative time was longer (439 vs 360 min, P < 0.001). Between RPD and LPD, overall survival was not significantly different (75.8 % vs 47.4 %, P = 0.098) and lymph node yield was higher in RPD (21 vs 18, P = 0.014). Conclusion: In conclusion, patients with AAC seem to have comparable oncological resection and perioperative outcomes from MIPD compared to the traditional OPD. Both RPD as LPD appear to be safe alternatives for patients with AAC, which warrants confirmation by future randomized studies.
AB - Background: Ampullary adenocarcinoma (AAC) typically presents at an early stage due to biliary obstruction and therefore might be specifically suitable for minimally invasive pancreatoduodenectomy (MIPD). However, studies assessing MIPD specifically for AAC, including the robotic and laparoscopic approach, are limited. The aim of this study is to compare short- and long-term oncological resection and perioperative outcomes of robotic (RPD), laparoscopic (LPD) and open pancreatoduodenectomy (OPD) performed specifically for AAC. Methods: In this multicenter international cohort study, encompassing 35 centers from 11 countries, MIPD versus OPD and subgroup analyses of LPD versus RPD were undertaken. The primary outcomes regarded the oncological resection (R1 resection rate, lymph node yield) and 5-years overall survival. Secondary outcomes were perioperative outcomes (including intra-operative variables, surgical complications and hospital stay). Results: In total, patients with AAC who underwent OPD (1721) or MIPD (141) were included. After propensity-score matching, 134 patients per cohort were included. The MIPD group consisted of 53 RPDs and 71 LPDs (50 per group after PSM). There was no difference in overall survival between MIPD and OPD (61.6 % vs 56.2 %, P = 0.215). In the MIPD group, operative time was longer (439 vs 360 min, P < 0.001). Between RPD and LPD, overall survival was not significantly different (75.8 % vs 47.4 %, P = 0.098) and lymph node yield was higher in RPD (21 vs 18, P = 0.014). Conclusion: In conclusion, patients with AAC seem to have comparable oncological resection and perioperative outcomes from MIPD compared to the traditional OPD. Both RPD as LPD appear to be safe alternatives for patients with AAC, which warrants confirmation by future randomized studies.
U2 - 10.1016/j.hpb.2024.11.013
DO - 10.1016/j.hpb.2024.11.013
M3 - Article
SN - 1365-182X
VL - 27
SP - 318
EP - 329
JO - HPB
JF - HPB
IS - 3
ER -